Ibandronic acid (INN) or ibandronate sodium (USAN), marketed under the trade names Boniva, Bondronat and Bonviva, is a potent bisphosphonate drug used in the prevention and treatment of osteoporosis.
It may also be used to treat hypercalcemia (elevated blood calcium levels). It is marketed and manufactured by GlaxoSmithKline and Roche Laboratories. Global sales in 2008 were 1.1B CHF ($1.0B USD at 01/01/2009 exchange rates).
Read more about Ibandronic Acid: Medical Uses, Adverse Effects